305 related articles for article (PubMed ID: 16691370)
21. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
Katagiri YU; Sleeman J; Fujii H; Herrlich P; Hotta H; Tanaka K; Chikuma S; Yagita H; Okumura K; Murakami M; Saiki I; Chambers AF; Uede T
Cancer Res; 1999 Jan; 59(1):219-26. PubMed ID: 9892210
[TBL] [Abstract][Full Text] [Related]
22. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
23. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
[TBL] [Abstract][Full Text] [Related]
24. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.
Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR
Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Huang J; Pan C; Hu H; Zheng S; Ding L
PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
[TBL] [Abstract][Full Text] [Related]
26. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
[TBL] [Abstract][Full Text] [Related]
27. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
[TBL] [Abstract][Full Text] [Related]
29. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
30. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
[TBL] [Abstract][Full Text] [Related]
31. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of osteopontin and CD44v9 in gastric cancer.
Ue T; Yokozaki H; Kitadai Y; Yamamoto S; Yasui W; Ishikawa T; Tahara E
Int J Cancer; 1998 Apr; 79(2):127-32. PubMed ID: 9583725
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages.
Gao C; Guo H; Wei J; Kuo PC
Biochem Biophys Res Commun; 2003 Sep; 309(1):120-5. PubMed ID: 12943672
[TBL] [Abstract][Full Text] [Related]
34. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
[TBL] [Abstract][Full Text] [Related]
35. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
36. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
37. Role of osteopontin in cellular signaling and toxicant injury.
Denhardt DT; Giachelli CM; Rittling SR
Annu Rev Pharmacol Toxicol; 2001; 41():723-49. PubMed ID: 11264474
[TBL] [Abstract][Full Text] [Related]
38. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
39. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin regulates multiple functions contributing to human colon cancer development and progression.
Irby RB; McCarthy SM; Yeatman TJ
Clin Exp Metastasis; 2004; 21(6):515-23. PubMed ID: 15679049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
